We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$691K
AUM Growth
+$78K
Cap. Flow
+$226M
Cap. Flow %
32,646.26%
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$61.5M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$54.4M
3
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$28.9M
4
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$16.7M
5
GLD icon
SPDR Gold Trust
GLD
+$9.38M

Top Sells

Rank Stock Value
1
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$10.7M
2
GIS icon
General Mills
GIS
+$5.39M
3
MSFT icon
Microsoft
MSFT
+$3.32M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$3.24M
5
ENR icon
Energizer
ENR
+$2.86M

Sector Composition

Rank Sector Weight
1 Energy 28.66%
2 Technology 9.15%
3 Healthcare 7.9%
4 Financials 6.09%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FANG icon
726
Diamondback Energy
FANG
$57.6B
$4 ﹤0.01%
100
– –
FHI icon
727
Federated Hermes
FHI
$4.4B
$4 ﹤0.01%
165
– –
GKOS icon
728
Glaukos
GKOS
$9.02B
$4 ﹤0.01%
+100
New +$3.72K
HMC icon
729
Honda
HMC
$36.5B
$4 ﹤0.01%
138
– –
HOG icon
730
Harley-Davidson
HOG
$2.68B
$4 ﹤0.01%
157
– –
HPE icon
731
Hewlett Packard
HPE
$63.2B
$4 ﹤0.01%
366
– –
HWM icon
732
Howmet Aerospace
HWM
$116B
$4 ﹤0.01%
251
-404
-62% -$5.31K
KSS icon
733
Kohl's
KSS
$2.03B
$4 ﹤0.01%
200
– –
MAT icon
734
Mattel
MAT
$4.17B
$4 ﹤0.01%
400
– –
MRVL icon
735
Marvell Technology
MRVL
$174B
$4 ﹤0.01%
100
– –
NHC icon
736
National Healthcare
NHC
$3.53B
$4 ﹤0.01%
60
– –
NTLA icon
737
Intellia Therapeutics
NTLA
$1.5B
$4 ﹤0.01%
+222
New +$3.77K
R icon
738
Ryder
R
$10.3B
$4 ﹤0.01%
100
– –
REFR icon
739
Research Frontiers
REFR
$16.1M
$4 ﹤0.01%
1,000
– –
SAR icon
740
Saratoga Investment
SAR
$309M
$4 ﹤0.01%
225
– –
TAK icon
741
Takeda Pharmaceutical
TAK
$55.1B
$4 ﹤0.01%
245
-150
-38% -$2.69K
TRP icon
742
TC Energy
TRP
$73.5B
$4 ﹤0.01%
100
– –
TTNP
743
DELISTED
Titan Pharmaceuticals
TTNP
$4 ﹤0.01%
+26
New +$4.48K
VYX icon
744
NCR Voyix
VYX
$1.06B
$4 ﹤0.01%
434
– –
WBD icon
745
Warner Bros
WBD
$64.6B
$4 ﹤0.01%
+228
New +$4.92K
YUMC icon
746
Yum China
YUMC
$14.9B
$4 ﹤0.01%
102
– –
ZTO icon
747
ZTO Express
ZTO
$18.2B
$4 ﹤0.01%
100
– –
HEXO
748
DELISTED
HEXO Corp. Common Shares
HEXO
$4 ﹤0.01%
+95
New +$3.44K
LOGM
749
DELISTED
LogMein, Inc.
LOGM
$4 ﹤0.01%
45
– –
TMUSR
750
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$4 ﹤0.01%
+82
New +$23
28 29
30
31 32

Similar funds

4FG
4Thought Financial Group Syosset, New York $202M AUM 11.53% 1-Year Est. Return
BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
CWM
CarsonAllaria Wealth Management Glen Carbon, Illinois $202M AUM 15.75% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
HWMO
Heritage Wealth Management (Ohio) Cincinnati, Ohio $202M AUM 23.85% 1-Year Est. Return
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
BSA
Bull Street Advisors Savannah, Georgia $202M AUM 11.06% 1-Year Est. Return

tru Independence's Q2 2020 Portfolio in Review

As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.

tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.

  • tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
  • tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
  • tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
  • tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
  • tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
  • tru Independence opened 207 new positions and closed 53 in Q2 2020.
  • tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.